ArticleInternational journal of cardiology. Heart & vasculature2020

Low-dose oral cyclophosphamide therapy reduces atherosclerosis progression by decreasing inflammatory cells in a murine model of atherosclerosis.

Yayoi Sato-Okabayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.